Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges

被引:36
作者
Brix, Klaudia [1 ]
McInnes, Joseph [1 ,2 ]
Al-Hashimi, Alaa [1 ]
Rehders, Maren [1 ]
Tamhane, Tripti [1 ]
Haugen, Mads H. [1 ,3 ]
机构
[1] Univ Bremen, Res Ctr MOLIFE Mol Life Sci, Res Area HLTH, D-28759 Bremen, Germany
[2] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium
[3] Norwegian Radium Hosp, Inst Canc Res, Oslo Univ Hosp, Oslo, Norway
关键词
Cysteine cathepsins; Legumain; SECRETORY GRANULE BIOGENESIS; THYROID EPITHELIAL-CELLS; ACTIVITY-BASED PROBES; ASPARAGINYL ENDOPEPTIDASE; INTRAMEMBRANE PROTEOLYSIS; PROTEOMIC IDENTIFICATION; EMERGING ROLES; LYSOSOMAL PROTEINASES; REGULATED SECRETION; PROTEASE FUNCTIONS;
D O I
10.1007/s00709-014-0730-0
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Proteases play essential roles in protein degradation, protein processing, and extracellular matrix remodeling in all cell types and tissues. They are also involved in protein turnover for maintenance of homeostasis and protein activation or inactivation for cell signaling. Proteases range in function and specificity, with some performing distinct substrate cleavages, while others accomplish proteolysis of a wide range of substrates. As such, different cell types use specialized molecular mechanisms to regulate the localization of proteases and their function within the compartments to which they are destined. Here, we focus on the cysteine family of cathepsin proteases and legumain, which act predominately within the endo-lysosomal pathway. In particular, recent knowledge on cysteine cathepsins and their primary regulator legumain is scrutinized in terms of their trafficking to endo-lysosomal compartments and other less recognized cellular locations. We further explore the mechanisms that regulate these processes and point to pathological cases which arise from detours taken by these proteases. Moreover, the emerging biological roles of specific forms and variants of cysteine cathepsins and legumain are discussed. These may be decisive, pathogenic, or even deadly when localizing to unusual cellular compartments in their enzymatically active form, because they may exert unexpected effects by alternative substrate cleavage. Hence, we propose future perspectives for addressing the actions of cysteine cathepsins and legumain as well as their specific forms and variants. The increasing knowledge in non-canonical aspects of cysteine cathepsin- and legumain-mediated proteolysis may prove valuable for developing new strategies to utilize these versatile proteases in therapeutic approaches.
引用
收藏
页码:755 / 774
页数:20
相关论文
共 255 条
[91]   Nuclear Legumain Activity in Colorectal Cancer [J].
Haugen, Mads H. ;
Johansen, Harald T. ;
Pettersen, Solveig J. ;
Solberg, Rigmor ;
Brix, Klaudia ;
Flatmark, Kjersti ;
Maelandsmo, Gunhild M. .
PLOS ONE, 2013, 8 (01)
[92]   Synthetic inhibitors of thrombin and factor Xa:: From bench to bedside [J].
Hauptmann, J ;
Stürzebecher, J .
THROMBOSIS RESEARCH, 1999, 93 (05) :203-241
[93]   LYST Affects Lysosome Size and Quantity, but not Trafficking or Degradation Through Autophagy or Endocytosis [J].
Holland, Petter ;
Torgersen, Maria L. ;
Sandvig, Kirsten ;
Simonsen, Anne .
TRAFFIC, 2014, 15 (12) :1390-1405
[94]   Alternative pathways for production of β-amyloid peptides of Alzheimer's disease [J].
Hook, Vivian ;
Schechter, Israel ;
Demuth, Hans-Ulrich ;
Hook, Gregory .
BIOLOGICAL CHEMISTRY, 2008, 389 (08) :993-1006
[95]   Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease [J].
Hook, Vivian ;
Funkelstein, Lydiane ;
Wegrzyn, Jill ;
Bark, Steven ;
Kindy, Mark ;
Hook, Gregory .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2012, 1824 (01) :89-104
[96]   Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce β-amyloid related to Alzheimer's disease [J].
Hook, Vivian ;
Hook, Gregory ;
Kindy, Mark .
BIOLOGICAL CHEMISTRY, 2010, 391 (08) :861-872
[97]   Inhibitors for the Immuno- and Constitutive Proteasome: Current and Future Trends in Drug Development [J].
Huber, Eva Maria ;
Groll, Michael .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (35) :8708-8720
[98]  
ISHII S, 1994, METHOD ENZYMOL, V244, P604
[99]   Membrane fusion and exocytosis [J].
Jahn, R ;
Südhof, TC .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :863-911
[100]   Cathepsin L expression is up-regulated by hypoxia in human melanoma cells:: role of its 5′-untranslated region [J].
Jean, Didier ;
Rousselet, Nathalie ;
Frade, Raymond .
BIOCHEMICAL JOURNAL, 2008, 413 :125-134